Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events

Journal of Women's Health
Naomi D HerzDaniel A Caños

Abstract

Multiple studies of heart failure patients demonstrated significant improvement in exercise capacity, quality of life, cardiac left ventricular function, and survival from cardiac resynchronization therapy (CRT), but the underenrollment of women in these studies is notable. Etiological and pathophysiological differences may result in different outcomes in response to this treatment by sex. The observed disproportionate representation of women suggests that many women with heart failure either do not meet current clinical criteria to receive CRT in trials or are not properly recruited and maintained in these studies. We performed a systematic literature review through May 2014 of clinical trials and registries of CRT use that stratified outcomes by sex or reported percent women included. One-hundred eighty-three studies contained sex-specific information. Ninety percent of the studies evaluated included ≤ 35% women. Fifty-six articles included effectiveness data that reported response with regard to specific outcome parameters. When compared with men, women exhibited more dramatic improvement in specific parameters. In the studies reporting hazard ratios for hospitalization or death, women generally had greater benefit from CRT....Continue Reading

References

Nov 13, 2002·Journal of the American College of Cardiology·Maria Vittoria PitzalisPaolo Rizzon
Jan 22, 2003·Journal of the American College of Cardiology·Frederick A MasoudiHarlan M Krumholz
Feb 20, 2003·BMC Cardiovascular Disorders·Jason M BursteinBeth L Abramson
Mar 14, 2003·European Heart Journal·J G F ClelandUNKNOWN Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology
Oct 29, 2003·Cardiology in Review·Ileana L Pĩna, Carol Buchter
Dec 19, 2003·Journal of the American College of Cardiology·Jalal K GhaliJoAnn Lindenfeld
Mar 12, 2004·Journal of the American College of Cardiology·Karen HoggJohn McMurray
May 21, 2004·The New England Journal of Medicine·Michael R BristowUNKNOWN Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators
Aug 18, 2004·Circulation·Philip B AdamsonUNKNOWN InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators
Nov 3, 2004·The American Journal of Cardiology·Wendy Y LeeUNKNOWN Epidemiology, Practice, Outcomes, and Cost of Heart Failure (EPOCH) Study
Nov 16, 2004·European Journal of Heart Failure·C OpasichUNKNOWN TEMISTOCLE Investigators
Nov 18, 2004·Pacing and Clinical Electrophysiology : PACE·Matthew R ReynoldsUNKNOWN Miracle ICD Investigators
Feb 11, 2005·European Journal of Heart Failure·J G F ClelandUNKNOWN CARE-HF study Steering Committee and Investigators
Mar 4, 2005·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Gregory W WooAnne B Curtis
Dec 20, 2005·Journal of the American College of Cardiology·Angel R LeónUNKNOWN InSync III Clinical Study Investigators
Jan 13, 2006·Pacing and Clinical Electrophysiology : PACE·Gabe B BleekerJeroen J Bax
Feb 21, 2006·The Journal of Cardiovascular Nursing·Marie Galvao, UNKNOWN ADHERE Scientific Advisory Committee (SAC) Investigators, Coordinators, and Study Group
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Jan 24, 2007·Journal of Cardiovascular Electrophysiology·Maurizio LunatiUNKNOWN InSync ICD Italian Registry Investigators
Jun 30, 2007·The American Journal of Cardiology·Ernesto Díaz-InfanteJosep Brugada
Nov 3, 2007·Pacing and Clinical Electrophysiology : PACE·Omeed ZardkoohiJagmeet P Singh
Nov 3, 2007·Pacing and Clinical Electrophysiology : PACE·Alessio LilliLuigi Padeletti
Feb 19, 2008·European Journal of Heart Failure·Markku S NieminenJose Luis Lopez-Sendon
Mar 28, 2008·Journal of Cardiovascular Electrophysiology·Hemal M NayakFrancis E Marchlinski
Apr 1, 2008·Pacing and Clinical Electrophysiology : PACE·Jamshid AlaeddiniKenneth A Ellenbogen
Jul 25, 2008·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Luigi AscioneBernardino Tuccillo
Aug 8, 2008·Pacing and Clinical Electrophysiology : PACE·Luigi AscioneJos Roelandt
Nov 20, 2008·Journal of the American College of Cardiology·Luigi Di BiaseUNKNOWN InSync/InSync ICD Italian Registry Investigators
Nov 29, 2008·Journal of the American College of Cardiology·Cecilia LindeUNKNOWN REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group
Dec 26, 2008·Gender Medicine·Ramezan Bakhshian KelarijaniYahya Dadjoo
Jan 30, 2009·Journal of Cardiovascular Electrophysiology·Steven M MarkowitzBruce B Lerman
Feb 26, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Natália AntónioLuís A Providência
Mar 11, 2009·Pacing and Clinical Electrophysiology : PACE·Giuseppe StabileAntonio De Simone
Jul 30, 2009·The International Journal of Cardiovascular Imaging·Haoying ShiShaowen Liu
Sep 1, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Anita WokhluYong-Mei Cha

❮ Previous
Next ❯

Citations

Aug 25, 2015·Current Cardiology Reports·C ButcherJ G F Cleland
Mar 15, 2018·Scandinavian Cardiovascular Journal : SCJ·Carina CarnlöfFredrik Gadler
Oct 21, 2017·Cardiology in Review·Yasameen AzarbaijaniRobbert Zusterzeel
Oct 17, 2019·ESC Heart Failure·Sarah J GutmanAndrew J Taylor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.